GoldenGolden
Indee Labs

Indee Labs

Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.

Edit ID  5312671 

Ryan Pawell
Ryan Pawell edited on 17 May, 2018
Edits made to:
Article (+93/-26 characters)
Article

In July 2017, Indee Labs closed USD$1.3M in accelerator and angel financing from Jude Gomila, Shaun Maguire and, Y Combinator and Jaffray Woodriff (executed by his family office, Felton Group, LLC) among others.

...

In May 2018, Indee Labs closed out a seed round resulting in USD$2.6M in angel and venture financing from Founders FundFounders Fund, Main Sequence Ventures, Social+Capital also among others.

...

Award
Funding Agency
Value
Year
Link

BioMedTech Horizons Precision Medicine

MTP Connect

AUD$891,500

2018-20202018-20

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.